These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27461397)

  • 1. Prevalence of electrocardiographic abnormalities based on hypertension severity and blood pressure levels: the Reasons for Geographic and Racial Differences in Stroke study.
    Bhatt H; Gamboa CM; Safford MM; Soliman EZ; Glasser SP
    J Am Soc Hypertens; 2016 Sep; 10(9):702-713.e4. PubMed ID: 27461397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there an association between the prevalence of atrial fibrillation and severity and control of hypertension? The REasons for Geographic And Racial Differences in Stroke study.
    Bhatt H; Gamboa CM; Safford MM; Soliman EZ; Glasser SP
    J Am Soc Hypertens; 2016 Jul; 10(7):578-586.e5. PubMed ID: 27324843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of hypertension severity and control with risk of incident atrial fibrillation: The REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
    Garg PK; Wilson N; Yuan Y; Howard VJ; Judd S; Howard G; Soliman EZ
    Clin Cardiol; 2023 Nov; 46(11):1418-1425. PubMed ID: 37605862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular Health and Transition From Controlled Blood Pressure to Apparent Treatment Resistant Hypertension: The Jackson Heart Study and the REGARDS Study.
    Akinyelure OP; Sakhuja S; Colvin CL; Clark D; Jaeger BC; Hardy ST; Howard G; Cohen LP; Irvin MR; Tanner R; Carey RM; Muntner P
    Hypertension; 2020 Dec; 76(6):1953-1961. PubMed ID: 33131312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Muntner P; Davis BR; Cushman WC; Bangalore S; Calhoun DA; Pressel SL; Black HR; Kostis JB; Probstfield JL; Whelton PK; Rahman M;
    Hypertension; 2014 Nov; 64(5):1012-21. PubMed ID: 25259745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management Practices in Indian Patients with Uncontrolled Hypertension.
    Bharatia R; Chitale M; Saxena GN; Kumar RG; Chikkalingaiah ; Trailokya A; Dalvi K; Talele S
    J Assoc Physicians India; 2016 Jul; 64(7):14-21. PubMed ID: 27759337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack.
    Howard VJ; Tanner RM; Anderson A; Irvin MR; Calhoun DA; Lackland DT; Oparil S; Muntner P
    Am J Med; 2015 Jul; 128(7):707-14.e2. PubMed ID: 25770032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality.
    Irvin MR; Booth JN; Shimbo D; Lackland DT; Oparil S; Howard G; Safford MM; Muntner P; Calhoun DA
    J Am Soc Hypertens; 2014 Jun; 8(6):405-13. PubMed ID: 24952653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and Predictors of Apparent Treatment-Resistant Hypertension in Real-World Populations Using Electronic Health Record-Based Data.
    Jafari E; Cooper-DeHoff RM; Effron MB; Hogan WR; McDonough CW
    Am J Hypertens; 2024 Jan; 37(1):60-68. PubMed ID: 37712350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of major and minor ECG abnormalities with traditional cardiovascular risk factors in the general population: a large scale study.
    Sahranavard T; Alimi R; Arabkhazaei J; Nasrabadi M; Alavi Dana SMM; Gholami Y; Izadi-Moud A; Esmaily H; Ebrahimi M; Ferns GA; Moohebati M; Saffar Soflaei S; Ghayour Mobarhan M
    Sci Rep; 2024 May; 14(1):11289. PubMed ID: 38760424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health care fragmentation and blood pressure control among adults taking antihypertensive medication.
    Colvin CL; Safford MM; Muntner P; Colantonio LD; Kern LM
    Am J Manag Care; 2022 Mar; 28(3):108-115. PubMed ID: 35404546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistant hypertension and cardiovascular disease mortality in the US: results from the National Health and Nutrition Examination Survey (NHANES).
    Kaczmarski KR; Sozio SM; Chen J; Sang Y; Shafi T
    BMC Nephrol; 2019 Apr; 20(1):138. PubMed ID: 31023262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004.
    Wong ND; Lopez VA; L'Italien G; Chen R; Kline SE; Franklin SS
    Arch Intern Med; 2007 Dec; 167(22):2431-6. PubMed ID: 18071164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and characteristics of apparent treatment-resistant hypertension in older people in China: a cross-sectional study.
    Wu C; Wang Y; Zhang W; Li X; Wang L; Hui R
    Clin Exp Hypertens; 2019; 41(8):753-758. PubMed ID: 30512984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network.
    Egan BM; Zhao Y; Li J; Brzezinski WA; Todoran TM; Brook RD; Calhoun DA
    Hypertension; 2013 Oct; 62(4):691-7. PubMed ID: 23918752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of pseudoresistant hypertension due to inaccurate blood pressure measurement.
    Bhatt H; Siddiqui M; Judd E; Oparil S; Calhoun D
    J Am Soc Hypertens; 2016 Jun; 10(6):493-9. PubMed ID: 27129931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No Time to Waste: in Support of Aggressive and Immediate Management of Hypertension.
    Fudim M; Vemulapalli S
    Curr Hypertens Rep; 2016 Apr; 18(4):26. PubMed ID: 26949264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and clinical characteristics of apparent therapy-resistant hypertension in patients with cardiovascular disease: a cross-sectional cohort study in secondary care.
    de Beus E; van der Sande NGC; Bots ML; Spiering W; Voskuil M; Visseren FLJ; Blankestijn PJ
    BMJ Open; 2017 Sep; 7(9):e016692. PubMed ID: 28882918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study.
    Brambilla G; Bombelli M; Seravalle G; Cifkova R; Laurent S; Narkiewicz K; Facchetti R; Redon J; Mancia G; Grassi G
    J Hypertens; 2013 Oct; 31(10):2018-24. PubMed ID: 23838657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Apparent Therapy-Resistant Hypertension and Its Effect on Outcome in Patients With Chronic Kidney Disease.
    de Beus E; Bots ML; van Zuilen AD; Wetzels JF; Blankestijn PJ;
    Hypertension; 2015 Nov; 66(5):998-1005. PubMed ID: 26351024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.